Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank17
3Y CAGR-18.4%
5Y CAGR-8.5%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-18.4%/yr
Annual compound
5Y CAGR
-8.5%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineCompressed
PeriodValueYoY Change
20255.04-14.0%
20245.86-16.0%
20236.97-24.7%
20229.26-28.8%
202113.01+65.5%
20207.86+144.1%
20193.22-